Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus
Open Access
- 1 February 2006
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (2) , 428-438
Abstract
As an aggressive pathogen, Staphylococcus aureus poses a significant public health threat and is becoming increasingly resistant to currently available antibiotics, including vancomycin, the drug of last resort for gram-positive bacterial infections. S. aureus with intermediate levels of resistance to vancomycin (vancomycin-intermediate S. aureus [VISA]) was first identified in 1996. The resistance mechanism of VISA, however, has not yet been clarified. We have previously shown that cell wall thickening is a common feature of VISA, and we have proposed that a thickened cell wall is a phenotypic determinant for vancomycin resistance in VISA (L. Cui, X. Ma, K. Sato, et al., J. Clin. Microbiol. 41: 5-14, 2003). Here we show the occurrence of an anomalous diffusion of vancomycin through the VISA cell wall, which is caused by clogging of the cell wall with vancomycin itself. A series of experiments demonstrates that the thickened cell wall of VISA could protect ongoing peptidoglycan biosynthesis in the cytoplasmic membrane from vancomycin inhibition, allowing the cells to continue producing nascent cell wall peptidoglycan and thus making the cells resistant to vancomycin. We conclude that the cooperative effect of the clogging and cell wall thickening enables VISA to prevent vancomycin from reaching its true target in the cytoplasmic membrane, exhibiting a new class of antibiotic resistance in gram-positive pathogens.Keywords
This publication has 50 references indexed in Scilit:
- DNA Microarray-Based Identification of Genes Associated with Glycopeptide Resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- Septic Arthritis Caused by Vancomycin-Intermediate Staphylococcus aureusJournal of Clinical Microbiology, 2005
- Microarray Transcription Analysis of Clinical Staphylococcus aureus Isolates Resistant to VancomycinJournal of Bacteriology, 2003
- Increased Glycan Chain Length Distribution and Decreased Susceptibility to Moenomycin in a Vancomycin-Resistant Staphylococcus aureus MutantAntimicrobial Agents and Chemotherapy, 2002
- A Spectrum of Changes Occurs in Peptidoglycan Composition of Glycopeptide-Intermediate Clinical Staphylococcus aureus IsolatesAntimicrobial Agents and Chemotherapy, 2001
- Involvement of multiple genetic loci inStaphylococcus aureusteicoplanin resistanceFEMS Microbiology Letters, 2001
- Vancomycin-intermediate Staphylococcus aureus at a Scottish HospitalJournal of Infection, 2000
- Identification of the Up- and Down-Regulated Genes in Vancomycin-Resistant Staphylococcus aureus Strains Mu3 and Mu50 by cDNA Differential Hybridization MethodBiochemical and Biophysical Research Communications, 2000
- THE STRUCTURE AND MODE OF ACTION OF GLYCOPEPTIDE ANTIBIOTICS OF THE VANCOMYCIN GROUPAnnual Review of Microbiology, 1984
- Vancomycin concentration in human tissues —preliminary reportJournal of Antimicrobial Chemotherapy, 1979